Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 24, 2019 08:30 ET | Source: Liquidia Technologies, Inc.

Liquidia Technologies Announces $22.4 Million Private Placement

RESEARCH TRIANGLE PARK, N.C., Dec. 24, 2019 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc. (Nasdaq:LQDA) (“Liquidia”), a late-stage clinical biopharmaceutical company focused on the development and...
November 13, 2019 07:00 ET | Source: Liquidia Technologies, Inc.

Liquidia Technologies Reports Third Quarter 2019 Financial Results and Provides Corporate Update

Completed Registrational Studies of LIQ861 to Include in New Drug Application (NDA)Targeting Submission of NDA for LIQ861 in 1Q 2020Management to Host Webcast and Conference Call Today at 8:00 a.m. ET...
November 06, 2019 08:00 ET | Source: Liquidia Technologies, Inc.

Liquidia to Report Third Quarter 2019 Financial Results and Provide Corporate Update on November 13, 2019

RESEARCH TRIANGLE PARK, N.C., Nov. 06, 2019 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc. (Nasdaq: LQDA) (“Liquidia” or the “Company”), a late-stage clinical biopharmaceutical company, today...
November 01, 2019 08:00 ET | Source: Liquidia Technologies, Inc.

Liquidia Technologies Appoints Industry Veteran Katie Rielly-Gauvin to Board of Directors

RESEARCH TRIANGLE PARK, N.C., Nov. 01, 2019 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc. (Nasdaq: LQDA) (“Liquidia” or the “Company”), a late-stage clinical biopharmaceutical company, today...
September 25, 2019 16:05 ET | Source: Liquidia Technologies, Inc.

Liquidia to Present at Cantor 2019 Global Healthcare Conference

RESEARCH TRIANGLE PARK, N.C., Sept. 25, 2019 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc. (Nasdaq: LQDA) (“Liquidia” or the “Company”), a late-stage clinical biopharmaceutical company, announced...
September 12, 2019 16:05 ET | Source: Liquidia Technologies, Inc.

Liquidia Technologies Appoints Industry Veteran Dr. Joanna Horobin to Board of Directors

RESEARCH TRIANGLE PARK, N.C., Sept. 12, 2019 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc. (Nasdaq: LQDA) (“Liquidia” or the “Company”), a late-stage clinical biopharmaceutical company, today...
September 03, 2019 07:00 ET | Source: Liquidia Technologies, Inc.

Liquidia to Present at H.C. Wainwright Healthcare Conference

RESEARCH TRIANGLE PARK, N.C., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc. (Nasdaq: LQDA) (“Liquidia” or the “Company”), a late-stage clinical biopharmaceutical company, announced...
August 08, 2019 16:05 ET | Source: Liquidia Technologies, Inc.

Liquidia to Present at Wedbush PacGrow Healthcare Conference

RESEARCH TRIANGLE PARK, N.C., Aug. 08, 2019 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc. (Nasdaq: LQDA) (“Liquidia” or the “Company”), a late-stage clinical biopharmaceutical company, announced...
August 08, 2019 07:00 ET | Source: Liquidia Technologies, Inc.

Liquidia Technologies Reports Second Quarter 2019 Financial Results and Provides Corporate Update

On Track for Planned New Drug Application (NDA) Submission for LIQ861 in Late 2019 Continued Pipeline Progress Leveraging Proprietary PRINT® Technology Management to Host Webcast and Conference Call...
August 02, 2019 09:00 ET | Source: Liquidia Technologies, Inc.

Liquidia to Report Second Quarter 2019 Financial Results and Provide Corporate Update on August 8, 2019

RESEARCH TRIANGLE PARK, N.C., Aug. 02, 2019 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc. (Nasdaq:LQDA) (“Liquidia”), a late-stage clinical biopharmaceutical company focused on the development and...